報告題目：Dendrimers and metallodrugs in the fight against cancer
報告人：João Rodrigues教授
University of Madeira (Madeira Island/Portugal) (葡萄牙馬德拉大學(xué))
報告時間：2014年4月10日（周四）10:00 -11:15
報告地點(diǎn)：化學(xué)樓一號會議室
報告人簡歷：
Since 1997, Dr. João Rodrigues is professor at the University of Madeira (Madeira Island/Portugal), and responsible for the areas of general chemistry, inorganic/organometallic chemistry, nanochemistry and nanomaterials. He is also:
Head and Scientific Coordinator of the Centro de Química da Madeira/Madeira Chemistry Research Center -National Laboratory (2006 - …),
Leader of the Molecular Materials Research Group (2001 - …),,
Director of the Master in Nanochemistry and Nanomaterials (2012 - …),
Managing Board member of the National Network Facilities of Nuclear Magnetic Resonance and Mass Spectrometry (2007 - …),
Member of the Academic Senate and of the General Council of the University of Madeira (2013 - …),.
He was President of the Inorganic Chemistry Division/ Portuguese Chemistry Society (2003-2005) and is a former member of the National Committee for the celebration of the International Year of Chemistry 2011.
Presently, he is member of the Regional Board responsible for the roadmap for Health in the framework of “Horizon 2020” (A European strategy for smart, sustainable and inclusive growth, launched by the European Commission in March 2010) at Madeira Island (Portugal), member of the “National Technical Advisory Team of 7th FP – Cooperation, Theme 4: Nanosciences, Nanotechnologies, Materials, and New Production Technologies (NMP)”.
His scientific work has been mainly devoted to the preparation and characterization of potential useful molecular materials, namely dendritic(hyperbranched), polymeric metal-containing systems and nanoparticles, having in view their potential use as electronic and/or biomedical nanomaterials. The total budget managed as Principal Investigator represents more than 1.5kM euros. He is author of 41 peer-reviewed articles, 1 book chapter, 7 proceeding papers, 19 invited lectures and 50 other oral presentations.
